Table: Kubota Pharmaceutical Holdings -6-MTH group results (IFRS)

Kubota Pharmaceutical Holdings

12/08/2022 07:00

Aug 12 (Reuters)- 
              Kubota Pharmaceutical Holdings Co., Ltd. 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   6 months ended      6 months ended        Year to  
                  Jun 30, 2022        Jun 30, 2021      Dec 31, 2022  
                     LATEST             YEAR-AGO           COMPANY    
                     RESULTS             RESULT           FORECAST    
  Operating         loss 1.17           loss 1.34         loss 2.00   
  Pretax            loss 1.20           loss 1.35         loss 2.00   
  Net               loss 1.20           loss 1.35         loss 2.00   
  EPS Basic      loss 26.02 yen      loss 29.86 yen    loss 43.61 yen 
  EPS Diluted    loss 26.02 yen      loss 29.86 yen                   
  Ann Div                                  NIL               NIL      
  -Q2 Div              NIL                 NIL                        
  -Q4 Div                                  NIL               NIL      
 
  NOTE - Kubota Pharmaceutical Holdings Co., Ltd.. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4596.T